Received Apr 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
His father passed away a few years ago; had a case of shingles after receiving the first dose of SHINGRIX/had blister underneath his eyes; This serious case was reported by a consumer via call center representative and described the occurrence of death in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced death (Verbatim: His father passed away a few years ago) (serious criteria death and GSK medically significant) and facial herpes zoster (Verbatim: had a case of shingles after receiving the first dose of SHINGRIX/had blister underneath his eyes). The outcome of the facial herpes zoster was not reported. The reported cause of death was unknown. It was unknown if the reporter considered the death and facial herpes zoster to be related to Shingrix. The company considered the death to be unrelated to Shingrix. It was unknown if the company considered the facial herpes zoster to be related to Shingrix. Additional Information: GSK Receipt Date: 20-APR-2026 The caller mentioned his father had a case of shingles after receiving the first dose of Shingrix. The patient had blister underneath his eyes. It was awful. His father passed away a few years ago and the son did not want to provide any information. The batch number was not provided and unable to contact the reporter.; Sender's Comments: A case of Death, unknown time after receiving Shingrix, in a male patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.; Reported Cause(s) of Death: Unknown cause of death